News
- Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in DogsMarch 24, 2020 8:31 AM EDT
- Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial ResultsMarch 16, 2020 4:02 PM EDT
- Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 4:02 PM EST
Events
- Monday, March 16, 2020 4:30 PM EDT
- Monday, February 24, 2020 from 12:50 PM to 1:30 PM EST
- Wednesday, January 8, 2020 4:30 PM EST
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
Events & Presentations